Huntington Wins 2012 Expect Miracles “Company For A Cure” Award

“Huntington’s support has surpassed even our highest expectations. Not only has it provided Pelotonia with financial support, it has fully engaged its entire operation. From riders to volunteers to supporters, each is doing their part to end cancer,” said Tom Lennox, founder and chief executive director of Pelotonia. “Because of the commitment and passion of Huntington, and other partners alike, a cure will be found sooner.”

In 2011, Huntington raised more than $2 million for The Ohio State University Comprehensive Cancer Center—a 30 percent increase over 2010’s fundraising efforts. The bank has set a $2.5 million fundraising goal for 2012.

“The support of the Huntington Bank family has been critical to the millions of dollars raised through Pelotonia,” said Dr. Michael Caligiuri, director of The Ohio State University Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute. “Cancer is a complex disease that differs in each person. No two cancers are alike, and there is no one-size-fits-all way to prevent, detect, treat and cure. Our brightest hope for creating a world without cancer lies in research. With the support of Huntington employees, and thousands of other dedicated Pelotonia riders, volunteers and donors, we are raising funds needed to fuel the cancer discoveries of tomorrow right here at Ohio State.”

The annual awards, which were established in 2010 and are sponsored by American Century Investments, recognize individuals and firms within the financial community for outstanding support and commitment in the fight against cancer. The categories of recognition included: Corporate Commitment Award, Company for a Cure Award, Miracle Maker Leadership Award and Inspiration Contributor Award.

Expect Miracles Foundation, formerly Mutual Funds Against Cancer, is one of the leading advocates in the fight against cancer within the financial services industry. Proceeds benefit cancer patient care initiatives nation-wide and cutting-edge cancer research at the Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute.

« First ‹ Previous 1 2 3 Next › Last »